Skip to main content
Signal8

ProPhase Labs, Inc. (PRPH)

ProPhase Labs, Inc., founded in 1989 in Garden City, New York (and previously known as The Quigley Corporation), operates as a diversified company with two main areas of focus: Consumer Products and Diagnostic Services. Through its Consumer Products division, ProPhase Labs is actively involved in the entire process—from researching and developing to manufacturing, distributing, marketing, and selling—a range of over-the-counter (OTC) healthcare items and nutritional supplements within the United States. Notable offerings include dietary supplements like Legendz XL, which supports male sexual health, and Triple Edge XL, formulated to enhance energy and stamina. The Diagnostic Services segment provides crucial testing solutions, including PCR tests for SARS-CoV-2 (COVID-19) and its variant mutations, using both saliva and nasal swab collection methods. This segment also offers molecular testing for other respiratory pathogens and supplies personal genomics products and services. Additionally, ProPhase Labs extends its capabilities by providing comprehensive contract manufacturing services, covering product development, pre-commercialization activities, production, warehousing, and distribution. The company's diverse products and services reach consumers through a broad network of national chain drug stores, various regional retailers, and online platforms.

Sector: Pharmaceutical Preparations

Industry: Medical - Pharmaceuticals

ProPhase Labs, Inc. logo

ProPhase Labs, Inc.

OTC:PRPHHealthcare
-2.17%$0.0090
Mkt Cap$140K
Float3.77M
O/S15.59M
Inst Own0.0%
Dilution
Historical Data
DateOpenHighLowCloseVolume
Key Metrics
Market Cap$140,333
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership0.00%

based on 15.59M shares outstanding

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ExchangeOTC
CountryUSUS
IPO DateApr 4, 1994
Shares Outstanding15.59M
Float3.77M
Company Overview

ProPhase Labs, Inc., founded in 1989 in Garden City, New York (and previously known as The Quigley Corporation), operates as a diversified company with two main areas of focus: Consumer Products and Diagnostic Services. Through its Consumer Products division, ProPhase Labs is actively involved in the entire process—from researching and developing to manufacturing, distributing, marketing, and selling—a range of over-the-counter (OTC) healthcare items and nutritional supplements within the United States. Notable offerings include dietary supplements like Legendz XL, which supports male sexual health, and Triple Edge XL, formulated to enhance energy and stamina. The Diagnostic Services segment provides crucial testing solutions, including PCR tests for SARS-CoV-2 (COVID-19) and its variant mutations, using both saliva and nasal swab collection methods. This segment also offers molecular testing for other respiratory pathogens and supplies personal genomics products and services.

Additionally, ProPhase Labs extends its capabilities by providing comprehensive contract manufacturing services, covering product development, pre-commercialization activities, production, warehousing, and distribution.

The company's diverse products and services reach consumers through a broad network of national chain drug stores, various regional retailers, and online platforms.

Leadership

Eleanor McBrier

Director

Jason Barr

Director

Louis Gleckel, MD

Director

Ted Karkus

Chairman of the Board and Chief Executive Officer

Employees

96

Country

US

Sector

Healthcare

Website

prophaselabs.com

Analyst Coverage
Analyst Coverage
ConsensusBuy
Price Target
No price targets available
Ratings Distribution
BUY
1
HOLD
1
SELL
0
TOTAL2
Insider Trades
InsiderTypeShares
Karkus Ted William profile photoKarkus Ted WilliamGrant/Award500.0K
Hollenshead Stuart profile photoHollenshead StuartGrant/Award500.0K
Hirsch Warren profile photoHirsch WarrenGrant/Award100.0K
GLECKEL LOUIS MD profile photoGLECKEL LOUIS MDGrant/Award100.0K
Shareholders
0.0%
Institutional
(2)
0.0%
Insiderⓘ
(0)
7.8%
5%+ Owners
(2)
of which 2.4% rests on schedules older than 24 months (1 holder)
92.2%
Unattributed (incl. retail)ⓘ
Institutional0.0%
5%+ Beneficial7.8%
Unattributed (incl. retail)92.2%
Top Shareholders
NameShares%
Venkatesan Shyam logo
Venkatesan Shyam
· may incl. warrants· filed Oct 2026
855.1K5.5%
Ted Karkus logo
Ted Karkus
· may incl. warrants· stale · filed Mar 2024
368.4K2.4%
CoreCap Advisors, LLC logo
CoreCap Advisors, LLC
100.0%
Farther Finance Advisors, LLC logo
Farther Finance Advisors, LLC
100.0%
Sources: 13F, 13D/13GO/S: 15.6M · as of 17 Aug 2026 · SEC cover page
Insiders & Institutional Holders

Insiders

52-Week Range
$0.0080$4.21
$0.0090(0th percentile)
Volume
Average Daily Volume528.29K
76.29K today vs 528.29K avg(-86%)

30d Avg

528.29K

60d Avg

373.10K

90d Avg

333.45K

Earnings
Dividend History
TTM Yield
--
Paid annually
Annual (LTM)
--
Latest
$3.0000
May 24, 22
5Y Growth
--
Compliance Status
Loading compliance data...